+1 Recommend
0 collections
      • Record: found
      • Abstract: found
      • Article: not found

      mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice.

      The Journal of clinical investigation

      Adaptor Proteins, Signal Transducing, genetics, deficiency, Tumor Suppressor Proteins, TOR Serine-Threonine Kinases, therapeutic use, Sirolimus, metabolism, Ribosomal Protein S6 Kinases, physiology, antagonists & inhibitors, Proteins, Protein Processing, Post-Translational, pathology, enzymology, drug effects, Podocytes, Phosphorylation, Multiprotein Complexes, Mice, Mutant Strains, Mice, Knockout, Mice, Inbred C57BL, Mice, Membrane Proteins, Male, Glomerular Mesangium, Glomerular Basement Membrane, Enzyme Activation, Endoplasmic Reticulum, Disease Models, Animal, prevention & control, etiology, drug therapy, Diabetic Nephropathies, complications, Diabetes Mellitus, Type 2, Cell Differentiation, Carrier Proteins, Animals

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Diabetic nephropathy (DN) is among the most lethal complications that occur in type 1 and type 2 diabetics. Podocyte dysfunction is postulated to be a critical event associated with proteinuria and glomerulosclerosis in glomerular diseases including DN. However, molecular mechanisms of podocyte dysfunction in the development of DN are not well understood. Here we have shown that activity of mTOR complex 1 (mTORC1), a kinase that senses nutrient availability, was enhanced in the podocytes of diabetic animals. Further, podocyte-specific mTORC1 activation induced by ablation of an upstream negative regulator (PcKOTsc1) recapitulated many DN features, including podocyte loss, glomerular basement membrane thickening, mesangial expansion, and proteinuria in nondiabetic young and adult mice. Abnormal mTORC1 activation caused mislocalization of slit diaphragm proteins and induced an epithelial-mesenchymal transition-like phenotypic switch with enhanced ER stress in podocytes. Conversely, reduction of ER stress with a chemical chaperone significantly protected against both the podocyte phenotypic switch and podocyte loss in PcKOTsc1 mice. Finally, genetic reduction of podocyte-specific mTORC1 in diabetic animals suppressed the development of DN. These results indicate that mTORC1 activation in podocytes is a critical event in inducing DN and suggest that reduction of podocyte mTORC1 activity is a potential therapeutic strategy to prevent DN.

          Related collections

          Author and article information



          Comment on this article